Go Pro
NASDAQ:VMD

Viemed Healthcare (VMD) Stock Price, News & Analysis

Viemed Healthcare logo
$12.26 +0.12 (+0.99%)
Closing price 07/9/2026 04:00 PM Eastern
Extended Trading
$12.74 +0.48 (+3.96%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Viemed Healthcare Stock (NASDAQ:VMD)

Advanced

Key Stats

Today's Range
$12.02
$12.28
50-Day Range
$8.52
$12.26
52-Week Range
$5.93
$12.41
Volume
253,389 shs
Average Volume
334,004 shs
Market Capitalization
$470.05 million
P/E Ratio
33.14
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Viemed Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

VMD MarketRank™: 

Viemed Healthcare scored higher than 41% of companies evaluated by MarketBeat, and ranked 558th out of 845 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Viemed Healthcare has received no research coverage in the past 90 days.

  • Read more about Viemed Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Viemed Healthcare are expected to grow by 31.82% in the coming year, from $0.44 to $0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viemed Healthcare is 33.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viemed Healthcare is 33.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.37.

  • Price to Book Value per Share Ratio

    Viemed Healthcare has a P/B Ratio of 3.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Viemed Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    1.51% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently decreased by 7.61%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Viemed Healthcare does not currently pay a dividend.

  • Dividend Growth

    Viemed Healthcare does not have a long track record of dividend growth.

  • Search Interest

    Only 1 people have searched for VMD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $347,200.00 in company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viemed Healthcare's insider trading history.
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VMD Stock News Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Headlines

VMD Stock Analysis - Frequently Asked Questions

Viemed Healthcare's stock was trading at $7.43 at the beginning of 2026. Since then, VMD shares have increased by 65.0% and is now trading at $12.26.

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its earnings results on Tuesday, May, 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.03. The business had revenue of $75.41 million for the quarter, compared to analyst estimates of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a trailing twelve-month return on equity of 10.52%.
Read the conference call transcript
.

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
5/05/2026
Today
7/10/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:VMD
CIK
1729149
Fax
N/A
Employees
1,382
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
$0.37
Trailing P/E Ratio
33.14
Forward P/E Ratio
27.86
P/E Growth
N/A
Net Income
$14.93 million
Net Margins
5.20%
Pretax Margin
7.71%
Return on Equity
10.52%
Return on Assets
7.60%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
1.22
Quick Ratio
1.10

Sales & Book Value

Annual Sales
$270.28 million
Price / Sales
1.74
Cash Flow
$1.16 per share
Price / Cash Flow
10.54
Book Value
$3.78 per share
Price / Book
3.24

Miscellaneous

Outstanding Shares
38,340,000
Free Float
30,670,000
Market Cap
$470.05 million
Optionable
Not Optionable
Beta
1.10

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:VMD) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners